(Q44265128)

1 December 2017

title

Anti-amyloid beta activity of metallothionein-III is different from its neuronal growth inhibitory activity: structure-activity studies (English)

1 reference

1 December 2017

Yoshifumi Irie

1

1 reference

1 December 2017

Wing Ming Keung

series ordinal

2

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

960

1 reference

1 December 2017

issue

1-2

1 reference

1 December 2017

page(s)

228-234

1 reference

Regulation of metallothionein-III (GIF) mRNA in the brain of patients with Alzheimer disease is not impaired

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Effect of the two conserved prolines of human growth inhibitory factor (metallothionein-3) on its biological activity and structure fluctuation: comparison with a mutant protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Aggregation State and Neurotoxic Properties of Alzheimer Beta-Amyloid Peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Metallothionein-III antagonizes the neurotoxic and neurotrophic effects of amyloid beta peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Different protective roles in vitro of alpha- and beta-domains of growth inhibitory factor (GIF) on neuron injuries caused by oxygen free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Bioactivity of Metallothionein-3 Correlates with Its Novel .beta. Domain Sequence Rather Than Metal Binding Properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Neurotrophic action of Alzheimer's disease brain extract is due to the loss of inhibitory factors for survival and neurite formation of cerebral cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

The N-terminal portion of growth inhibitory factor is sufficient for biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

The function of metallothionein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

6 Standard isolation procedure for metallothionein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Metal-thiolate clusters in neuronal growth inhibitory factor (GIF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Metallothionein III is reduced in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

Chemical modulation of metallothionein I and III mRNA in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903891-X

10.1016/S0006-8993(02)03891-X

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference